Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (403)

51

Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance

enthalten in: Pharmacological reports : PR | 2022

von Flisiak, R. | Zarębska-Michaluk, D. | Rogalska, M. | +10

ErratumIn: Pharmacol Rep. 2022 Oct 3;:. - PMID 36190677

52

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults : A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

enthalten in: Annals of internal medicine | 2022

von Potter, G. | Bonnett, T. | Rubenstein, K. | +41

53

Early antiviral and supervisory dexamethasone treatment improve clinical outcomes of nonsevere COVID-19 patients

enthalten in: Medicine | 2022

von Sitasuwan, T. | Phisalprapa, P. | Srivanichakorn, W. | +20

54

A systematic review of acute and emergency care interventions for adolescents and adults with severe acute respiratory infections including COVID-19 in low- and middle-income countries

enthalten in: Journal of global health | 2022

von Garbern, S. | Relan, P. | O'Reilly, G. | +5

55

COVID-19, how to treat the disease during Fall 2022?

enthalten in: Revue medicale suisse | 2022

von Chollet, V. | Manuel, O. | De Vallière, S.

56

No effect of remdesivir or betamethasone on upper respiratory tract SARS-CoV-2 RNA kinetics in hospitalised COVID-19 patients : a retrospective observational study

enthalten in: Infectious diseases (London, England) | 2022

von Sourander, B. | Andersson, L. | Brink, M. | +7

57

DNA damage in peripheral blood lymphocytes of severely ill COVID-19 patients in relation to inflammatory markers and parameters of hemostasis

enthalten in: Mutagenesis | 2022

von Mihaljevic, O. | Zivancevic-Simonovic, S. | Cupurdija, V. | +5

58

Targeted therapy in Coronavirus disease 2019 (COVID-19) : Implication from cell and gene therapy to immunotherapy and vaccine

enthalten in: International immunopharmacology | 2022

von Shirzad, M. | Nourigorji, M. | Sajedi, A. | +6

59

Evaluation of the efficacy of oral nano-silymarin formulation in hospitalized patients with COVID-19 : A double-blind placebo-controlled clinical trial

enthalten in: Phytotherapy research : PTR | 2022

von Aryan, H. | Farahani, R. | Chamanara, M. | +6

60

Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals

enthalten in: JAMA network open | 2022

von Vo, A. | La, J. | Wu, J. | +7

ErratumIn: JAMA Netw Open. 2023 Feb 1;6(2):e231692. - PMID 36780167